<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">Ribavirin (Bausch Health Companies Inc., Bridgewater, NJ, USA) is a guanosine analogue antiviral drug that has been used to treat several viral infections, including hepatitis C virus, respiratory syncytial virus (RSV), and some viral hemorrhagic fevers. The 
 <italic>in vitro</italic> antiviral activity of ribavirin against SARS-CoV was estimated to be at a concentration of 50 μg/mL.
 <xref rid="bib29" ref-type="bibr">
  <sup>29</sup>
 </xref> However, it has the undesirable adverse effect of reducing hemoglobin, which is harmful for patients in respiratory distress.
 <xref rid="bib19" ref-type="bibr">
  <sup>19</sup>
 </xref>
</p>
